| 1 | [SID103260440] | Active | GI50 | 0.028 | Growth inhibitory activity against human cancer cell line in the NCI?s anticancer drug screening program [AID247402, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103260440 | | CID | 445354 | | Outcome | Active | | GI50 | 0.028 [uM] | | BioAssay | Growth inhibitory activity against human cancer cell line in the NCI?s anticancer drug screening program | | AID | 247402 | | BioAssay type | Literature | | Target | | | PubMed | 15743190 | | Data Table |  |
|
| 2 | [SID103260440] | Active | Kd | 0.036 | Binding affinity to bovine beta-lactoglobulins by fluorescence spectroscopy [AID445385, Type: Literature] | Beta-lactoglobulin [gi:125910] |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103260440 | | CID | 445354 | | Outcome | Active | | Kd | 0.036 [uM] | | BioAssay | Binding affinity to bovine beta-lactoglobulins by fluorescence spectroscopy | | AID | 445385 | | BioAssay type | Literature | | Target | Beta-lactoglobulin [gi:125910] | | PubMed | 19938842 | | Data Table |  |
|
| 3 | [SID103260440] | Active | Kd | 0.07 | Dissociation constant with retinol binding protein was determined [AID199394, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103260440 | | CID | 445354 | | Outcome | Active | | Kd | 0.07 [uM] | | BioAssay | Dissociation constant with retinol binding protein was determined | | AID | 199394 | | BioAssay type | Literature | | Target | | | PubMed | 10999486 | | Data Table |  |
|
| 4 | [SID103260440] | Active | Kd | 0.2 | Binding affinity to reindeer beta-lactoglobulin by fluorescence spectroscopy [AID445386, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103260440 | | CID | 445354 | | Outcome | Active | | Kd | 0.2 [uM] | | BioAssay | Binding affinity to reindeer beta-lactoglobulin by fluorescence spectroscopy | | AID | 445386 | | BioAssay type | Literature | | Target | | | PubMed | 19938842 | | Data Table |  |
|
| 5 | [SID26753110] | Active | Potency | 3.1623 | qHTS assay for small molecule agonists of estrogen receptor alpha signaling [AID588514, Type: confirmatory] | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 26753110 | | CID | 445354 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS assay for small molecule agonists of estrogen receptor alpha signaling | | AID | 588514 | | BioAssay type | confirmatory | | Target | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] | | PubMed | | | Data Table |  |
|
| 6 | [SID26753110] | Active | Potency | 3.1623 | qHTS assay for small molecule agonists of estrogen receptor alpha signaling [AID588514, Type: confirmatory] | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 26753110 | | CID | 445354 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS assay for small molecule agonists of estrogen receptor alpha signaling | | AID | 588514 | | BioAssay type | confirmatory | | Target | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] | | PubMed | | | Data Table |  |
|
| 7 | [SID26753110] | Active | Potency | 3.1623 | qHTS assay for small molecule agonists of estrogen receptor alpha signaling [AID588514, Type: confirmatory] | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 26753110 | | CID | 445354 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS assay for small molecule agonists of estrogen receptor alpha signaling | | AID | 588514 | | BioAssay type | confirmatory | | Target | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] | | PubMed | | | Data Table |  |
|
| 8 | [SID26753110] | Active | Potency | 3.1623 | qHTS assay for small molecule agonists of estrogen receptor alpha signaling [AID588514, Type: confirmatory] | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 26753110 | | CID | 445354 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS assay for small molecule agonists of estrogen receptor alpha signaling | | AID | 588514 | | BioAssay type | confirmatory | | Target | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] | | PubMed | | | Data Table |  |
|
| 9 | [SID17389530] | Active | Potency | 5.9672 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 5.9672 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 10 | [SID17389530] | Active | Potency | 5.9672 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 5.9672 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 11 | [SID104171352] | Active | Potency | 10.691 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 104171352 | | CID | 445354 | | Outcome | Active | | Potency | 10.691 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID17389530] | Active | Potency | 14.1254 | qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity [AID588834, Type: Literature] | KCNH2 gene product [Homo sapiens] [gi:325651834] |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity | | AID | 588834 | | BioAssay type | Literature | | Target | KCNH2 gene product [Homo sapiens] [gi:325651834] | | PubMed | 19583963 | | Data Table |  |
|
| 13 | [SID17389530] | Active | Potency | 14.1254 | qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity [AID588834, Type: Literature] | KCNH2 gene product [Homo sapiens] [gi:325651834] |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity | | AID | 588834 | | BioAssay type | Literature | | Target | KCNH2 gene product [Homo sapiens] [gi:325651834] | | PubMed | 19583963 | | Data Table |  |
|
| 14 | [SID17389530] | Active | Potency | 14.1254 | qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity [AID588834, Type: Literature] | KCNH2 gene product [Homo sapiens] [gi:325651834] |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity | | AID | 588834 | | BioAssay type | Literature | | Target | KCNH2 gene product [Homo sapiens] [gi:325651834] | | PubMed | 19583963 | | Data Table |  |
|
| 15 | [SID17389530] | Active | Potency | 14.1254 | qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity [AID588834, Type: Literature] | KCNH2 gene product [Homo sapiens] [gi:325651834] |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity | | AID | 588834 | | BioAssay type | Literature | | Target | KCNH2 gene product [Homo sapiens] [gi:325651834] | | PubMed | 19583963 | | Data Table |  |
|
| 16 | [SID17389530] | Active | Potency | 14.1254 | qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity [AID588834, Type: Literature] | KCNH2 gene product [Homo sapiens] [gi:325651834] |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity | | AID | 588834 | | BioAssay type | Literature | | Target | KCNH2 gene product [Homo sapiens] [gi:325651834] | | PubMed | 19583963 | | Data Table |  |
|
| 17 | [SID124883068] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 124883068 | | CID | 445354 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID103260440] | Active | IC50 | 25 | Cytotoxicity against human normal fibroblast after 1 day by MTT assay [AID404772, Type: Literature] | |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103260440 | | CID | 445354 | | Outcome | Active | | IC50 | 25 [uM] | | BioAssay | Cytotoxicity against human normal fibroblast after 1 day by MTT assay | | AID | 404772 | | BioAssay type | Literature | | Target | | | PubMed | 18511283 | | Data Table |  |
|
| 19 | [SID26753109] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26753109 | | CID | 445354 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 20 | [SID26753109] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26753109 | | CID | 445354 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 21 | [SID17389530] | Active | Potency | 37.578 | qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion [AID651758, Type: confirmatory] | interleukin 8 [Homo sapiens] [gi:186368] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 37.578 [uM] | | BioAssay | qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion | | AID | 651758 | | BioAssay type | confirmatory | | Target | interleukin 8 [Homo sapiens] [gi:186368] | | PubMed | | | Data Table |  |
|
| 22 | [SID17389530] | Active | Potency | 37.578 | qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion [AID651758, Type: confirmatory] | interleukin 8 [Homo sapiens] [gi:186368] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 37.578 [uM] | | BioAssay | qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion | | AID | 651758 | | BioAssay type | confirmatory | | Target | interleukin 8 [Homo sapiens] [gi:186368] | | PubMed | | | Data Table |  |
|
| 23 | [SID17389530] | Active | Potency | 37.578 | qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion [AID651758, Type: confirmatory] | interleukin 8 [Homo sapiens] [gi:186368] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 37.578 [uM] | | BioAssay | qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion | | AID | 651758 | | BioAssay type | confirmatory | | Target | interleukin 8 [Homo sapiens] [gi:186368] | | PubMed | | | Data Table |  |
|
| 24 | [SID17389530] | Active | Potency | 39.8107 | Cell Viability - LYMP2-022 [AID987, Type: confirmatory] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | Cell Viability - LYMP2-022 | | AID | 987 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID17389530] | Active | Potency | 39.8107 | Cell Viability - LYMP2-004 [AID966, Type: confirmatory] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | Cell Viability - LYMP2-004 | | AID | 966 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID17389530] | Active | Potency | 42.1632 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 42.1632 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 27 | [SID17389530] | Active | Potency | 42.1632 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 42.1632 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 28 | [SID17389530] | Active | Potency | 42.1632 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 42.1632 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 29 | [SID17389530] | Active | Potency | 42.1632 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 42.1632 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 30 | [SID17389530] | Active | Potency | 50.1187 | Cell Viability - LYMP2-005 [AID967, Type: confirmatory] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | Cell Viability - LYMP2-005 | | AID | 967 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID17389530] | Active | Potency | 50.1187 | Cell Viability - LYMP2-010 [AID981, Type: confirmatory] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | Cell Viability - LYMP2-010 | | AID | 981 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID17389530] | Active | Potency | 50.1187 | Cell Viability - LYMP2-012 [AID982, Type: confirmatory] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | Cell Viability - LYMP2-012 | | AID | 982 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID17389530] | Active | Potency | 50.1187 | Cell Viability - LYMP2-024 [AID988, Type: confirmatory] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | Cell Viability - LYMP2-024 | | AID | 988 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID17389530] | Active | Potency | 50.1187 | Cell Viability - LYMP2-018 [AID985, Type: confirmatory] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | Cell Viability - LYMP2-018 | | AID | 985 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID17389530] | Active | Potency | 50.1187 | Cell Viability - LYMP2-020 [AID986, Type: confirmatory] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | Cell Viability - LYMP2-020 | | AID | 986 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID17389530] | Active | Potency | 50.1187 | Cell Viability - LYMP2-003 [AID965, Type: confirmatory] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | Cell Viability - LYMP2-003 | | AID | 965 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID47193665] | Active | Potency | 50.1187 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 47193665 | | CID | 445354 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 38 | [SID47193665] | Active | Potency | 50.1187 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 47193665 | | CID | 445354 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 39 | [SID144204369] | Active | Potency | 68.5896 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 144204369 | | CID | 445354 | | Outcome | Active | | Potency | 68.5896 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 40 | [SID144204369] | Active | Potency | 68.5896 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 144204369 | | CID | 445354 | | Outcome | Active | | Potency | 68.5896 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 41 | [SID144204369] | Active | Potency | 68.5896 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 144204369 | | CID | 445354 | | Outcome | Active | | Potency | 68.5896 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 42 | [SID144204369] | Active | Potency | 68.5896 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 144204369 | | CID | 445354 | | Outcome | Active | | Potency | 68.5896 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 43 | [SID17389530] | Active | | | qHTS Assay for Tau Filament Binding [AID596, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | BioAssay | qHTS Assay for Tau Filament Binding | | AID | 596 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 44 | [SID17389530] | Active | | | qHTS Assay for Tau Filament Binding [AID596, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 17389530 | | CID | 445354 | | Outcome | Active | | BioAssay | qHTS Assay for Tau Filament Binding | | AID | 596 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 45 | [SID103260440] | Active | | | Binding affinity to His-tagged recombinant human sRBP expressed in Escherichia coli BL21(DE3) assessed as apparent dissociation constant after 5 mins by fluorescence spectrophotometric analysis [AID606062, Type: Literature] | Retinol-binding protein 4 [gi:62298174] |   View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103260440 | | CID | 445354 | | Outcome | Active | | BioAssay | Binding affinity to His-tagged recombinant human sRBP expressed in Escherichia coli BL21(DE3) assessed as apparent dissociation constant after 5 mins by fluorescence spectrophotometric analysis | | AID | 606062 | | BioAssay type | Literature | | Target | Retinol-binding protein 4 [gi:62298174] | | PubMed | 21591606 | | Data Table |  |
|
| 46 | [SID26753110] | Active | | | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP) [AID1471, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26753110 | | CID | 445354 | | Outcome | Active | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP) | | AID | 1471 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|
| 47 | [SID26753110] | Active | | | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP) [AID1471, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26753110 | | CID | 445354 | | Outcome | Active | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP) | | AID | 1471 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|
| 48 | [SID47193688] | Active | | | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 [AID652115, Type: screening] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 47193688 | | CID | 445354 | | Outcome | Active | | BioAssay | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 | | AID | 652115 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID47193665] | Active | | | RNA aptamer-based HTS for inhibitors of GRK2 [AID488847, Type: screening] | beta-adrenergic receptor kinase 1 [Homo sapiens] [gi:148539876] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 47193665 | | CID | 445354 | | Outcome | Active | | BioAssay | RNA aptamer-based HTS for inhibitors of GRK2 | | AID | 488847 | | BioAssay type | screening | | Target | beta-adrenergic receptor kinase 1 [Homo sapiens] [gi:148539876] | | PubMed | | | Data Table |  |
|
| 50 | [SID46393062] | Active | | | Experimentally measured binding affinity data derived from PDB [AID1811, Type: Literature] | Chain A, Crystallographic Refinement Of Human Serum Retinol Binding Protein At 2 Angstroms Resolutio [gi:157833637] |   View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 46393062 | | CID | 445354 | | Outcome | Active | | BioAssay | Experimentally measured binding affinity data derived from PDB | | AID | 1811 | | BioAssay type | Literature | | Target | Chain A, Crystallographic Refinement Of Human Serum Retinol Binding Protein At 2 Angstroms Resolutio [gi:157833637] | | PubMed | 2217163 | | Data Table |  |
|